Inventor
SUCHARD SUZANNE J
US20 patents
⚠️ This page may combine multiple inventors who share the name “SUCHARD SUZANNE J”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
BRISTOL MYERS SQUIBB CO
16 patentsUS9228018B2Jan 5, 2016
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO11 citations91
US8895010B2Nov 25, 2014
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO24 citations91
US7358074B2Apr 15, 2008
Human phosphatase RET31, and variants thereof
BRISTOL MYERS SQUIBB CO14 citations89
US11220550B2Jan 11, 2022
Antagonistic anti-CD40 antibodies and methods of antagonizing CD40 activity
BRISTOL MYERS SQUIBB CO12 citations85
US10919965B2Feb 16, 2021
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO3 citations83
US9908937B2Mar 6, 2018
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO5 citations83
US9765150B2Sep 19, 2017
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO5 citations82
US8981072B2Mar 17, 2015
Nucleic acids encoding antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO8 citations82
US10435475B2Oct 8, 2019
Method of using antibody polypeptides that antagonize CD40 to treat IBD
BRISTOL MYERS SQUIBB CO9 citations77
US11613585B2Mar 28, 2023
Nucleic acids encoding antagonistic CD40 monoclonal antibodies
BRISTOL MYERS SQUIBB CO3 citations72
US10196451B2Feb 5, 2019
Methods of treating immune diseases by administering antibody polypeptides that specifically bind CD40L
BRISTOL MYERS SQUIBB CO1 citations71
US11267888B2Mar 8, 2022
Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
BRISTOL MYERS SQUIBB CO2 citations67
US12012452B2Jun 18, 2024
Compositions monovalent for CD28 binding and methods of use
BRISTOL MYERS SQUIBB CO0 citations61
US11180567B2Nov 23, 2021
Antibody polypeptides that antagonize CD40L
BRISTOL MYERS SQUIBB CO0 citations61
US11912769B2Feb 27, 2024
Methods of treating systemic lupus erythematosus using a domain antibody directed against CD28
BRISTOL MYERS SQUIBB CO0 citations56
US11899017B2Feb 13, 2024
Predictive peripheral blood biomarker for checkpoint inhibitors
BRISTOL MYERS SQUIBB CO0 citations52
MCKINNON MURRAY
3 patentsUS9085629B2Jul 21, 2015
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY18 citations90
US8454959B2Jun 4, 2013
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY23 citations90
US8168759B2May 1, 2012
Compositions monovalent for CD28 binding and methods of use
MCKINNON MURRAY21 citations90